CAR T-Cell Therapy in RCC With Monty Pal, MD, FASCO

Monty Pal, MD, FASCO, co-director of City of Hope’s Kidney Cancer Program and head of their kidney and bladder cancer disease team, discusses his recent study presented at the Society for Immunotherapy of Cancer’s 37th Annual Meeting. Dr. Pal’s study focuses on the use of novel CAR T-cell therapy for renal cell carcinoma.